Hypokalaemic thyrotoxic periodic paralysis: Case report and review of an Oriental syndrome

Netherlands Journal of Medicine

Volumn 49, Issue 2, 1996, Pages 90-97

  Van Dam, G M ^a,c   Reisman, Y ^a   Van Wieringen, K ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b Military Peripheral Team   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Hypokalaemic thyrotoxic periodic paralysis

Indexed keywords

POTASSIUM CHLORIDE; PREDNISOLONE; PROPRANOLOL; PROPYLTHIOURACIL; THIAMAZOLE;

ADULT; CASE REPORT; DIFFERENTIAL DIAGNOSIS; HUMAN; HYPERTHYROIDISM; HYPOKALEMIC PERIODIC PARALYSIS; MALE; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; REVIEW; THYROTOXICOSIS;

EID: 0030221352     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/0300-2977(96)00014-9     Document Type: Review

References (77)

1. [1] Musgrave WA. Periodic palsy. The Philosophical Transactions and Collections to the End of the Year 1700, 1727;2:33.
2. [2] Shaknovitch. On a case of intermittent paraplegia. Russk Vrach 1882;32:537. [Abstracted in London Medical Record 1884;12:130.]
3. [2] Shaknovitch. On a case of intermittent paraplegia. Russk Vrach 1882;32:537. [Abstracted in London Medical Record 1884;12:130.]
4. [3] Rosenfeld M. Akute aufsteigende Lahmung bei Morbus Basedow. Berl Klin Wochenschr 1902;39:538.
5. [4] Dunlap HF, Kepler EJ. A syndrome resembling familial periodic paralysis occurring in the course of exophthalmic goiter. Endocrinology 1931;15:541-546.
6. [5] Yeo PP, O'Neill WC. Thyrotoxicosis and periodic paralysis. Med Grand Rounds 1984;3:10-25.
7. [6] Crane MG. Periodic paralysis associated with hyperthyroidism. Calif Med 1974;81:332-336.
8. [7] Hopf RA, Schneider PG. Hypokalemic periodic paralysis in a thyrotoxic white man. Missouri Med 1980;77:73-75.
9. [8] Papouchado M. Thyrotoxic periodic paralysis. J R Soc Med 1980;73:519-520.
10. [9] Schutta HS, Armitage JL. Thyrotoxic hypokalemic periodic paralysis. A fine structure study. J Neuropath Exp Neurol 1969;28:321-336.
11. [10] Shizume K, Shishiba Y, Sakuma M, et al. Studies of electrolyte metabolism in idiopathic and thyrotoxic periodic paralyses. I. Arteriovenous differences of electrolytes during induced paralysis. Metabolism 1966;15:138-152.
12. [11] Pearson CM, Kalyanaraman K. The periodic paralyses. In: Stanbury JB, Wyngaarden JB, Frederickson DS, eds. The metabolic basis of inherited disease, 3rd edn. New York: McGraw-Hill Book Company, 1972;1181 pp.
13. [12] Charness ME, Johns RJ. Hypokalemic periodic paralysis. Johns Hopkins Med 1978;143:148-153.
14. [13] Ali K. Hypokalemic periodic paralysis. Periodic variation in the muscle calcium pump activity. Arch Neurol 1972;26:543-546.
15. [14] Norris FH Jr, Clark EC, Biglieri EG. Studies in thyrotoxic periodic paralysis. J Neurol Sci 1972;13:431-442.
16. [15] Seed L. Periodic paralysis in a patient with exophthalmic goiter controlled by 6-propylthiouracil. West J Surg Obstet Gynecol 1947;55:640-646.
17. [16] Swanson JW, Kelly JJ Jr, McConahey WM. Neurologic aspects of thyroid dysfunction. Mayo Clinic Proc 1981;56:504-512.
18. [17] Ziegler DK. Familial periodic paralysis. Report of 2 families, with observations on the pathogenesis of the syndrome. Arch Intern Med 1949;84:419-430.
19. [18] Conway MJ, Seibel JA, Eaton RP. Thyrotoxicosis and periodic paralysis: improvement with beta blockade. Ann Intern Med 1974;81:332-336.
20. [19] Ferreiro JE, Arguelles DJ, Rams Jr H. Thyrotoxic periodic paralysis. Am J Med 1986;80:146-150.
21. [20] Streeten DHP. Periodic paralysis. In: Stanbury JB, Wyngaarden JB, Frederickson DS, eds. The metabolic basis of inherited disease, 2nd edn. New York: McGraw-Hill Book Company, 1966;905-938.
22. [21] Okinaka S, Shizume K, Iino S, et al. The association of periodic paralysis and hyperthyroidism in Japan. J Clin Endocrinol Metab 1957;17:1454-1459.
23. [22] Ee B, Cheah JS. Electrocardiographic changes in thyrotoxic periodic paralysis. J Electrocardiol 1979;12:263-279.
24. [23] Fisher J. Thyrotoxic paralysis with ventricular fibrillation. Arch Intern Med 1982;14-2:1362-1364.
25. [24] MacFadzean AJS, Yeung R. Periodic paralysis complicating thyrotoxicosis in Chinese. Br Med J 1967;1:451-455.
26. [25] Resnick S, Dorman JD, Engel WK. Thyrotoxic periodic paralysis. Am J Med 1969;47:831-836.
27. [26] Yeo PPB, Lee KO, Cheah JS. Thyrotoxic periodic paralysis: A study of 51 patients. In: Proceedings of the second congress of the Association of Southeast Asian nations (ASEAN) Federation of Endocrine Societies, 30 Nov-3 Dec, Bangkok, Thailand, 1983.
28. [27] Kusakabe T, Yoshida M, Nishikawa M. Thyrotoxic periodic paralysis: a peculiar case with unusual dystonic behavior and variable relations of paralysis to serum potassium levels. J Clin Endocrinol Metab 1976;43:730-740.
29. [28] Okihiro MM, Nordyke RA. Hypokalemic periodic paralysis: experimental precipitation with sodium liothyronine. J Am Med Assoc 1966;198:949-951.
30. [29] Nikolai TJ, Cooms GJ, McKenzie AK. Lymphocyte thyroiditis with spontaneously resolving hyperthyroidism and subacute thyroiditis. Long-term follow-up. Arch Intern Med 1981;141:1455-1458.
31. [30] Aitken RCB, O'Connor PJ. Muscular weakness after prolonged ingestion of thyroid. Br Med J 1962;2:99-100.
32. [31] Layzer B, Goldfield E. Periodic paralysis caused by abuse of thyroid hormone. Neurology 1974;24:949-952.
33. [32] McKenzie JM, Zakarija M. Hyperthyroidism. In: DeGroot LJ, ed. Endocrinology. Philadelphia: W.B. Saunders Company, 1989;646 pp.
34. [33] Engel AG. Thyroid function and periodic paralyses. Am J Med 1969;30:327-333.
35. [34] Bergeron L, Sternbach GL. Thyrotoxic periodic paralysis. Ann Emerg Med 1988;17:842-845.
36. [35] Okihiro NM, Beddow RM. Thyrotoxic periodic paralysis in Hawaii. Its predilection for the Japanese race. Neurology 1965;15:252-255.
37. [36] Talbott JH. Periodic paralyses: a clinical syndrome. Medicine 1941;20:85.
38. [37] Corbelt UA, Nuttal FQ. Familial hypokalemic periodic paralysis in blacks. Ann Intern Med 1975;83:63-65.
39. [38] Saeian K, Heckerling PS. Thyrotoxic periodic paralysis in a Hispanic man. Arch Intern Med 1988;148:708.
40. [39] Yeung RTT, Tse TF. Thyrotoxic periodic paralysis. Effect of propranolol. Am J Med 1974;57:584-590.
41. [40] Tamai H, Tanaka K, Komaki G, et al. HLA and thyrotoxic periodic paralysis in Japanese patients. J Clin Endocrinol Metab 1987;64(5);1075-1078.
42. [41] McArdle B. Familial periodic paralysis. Br Med Bull 1956;12:226.
43. [42] Johnson V, Winternitz WW. Hypokalemic periodic paralysis. South Med J 1984;77(9-):1207-1209.
44. [43] MacLachlan TK. Familial periodic paralysis: a description of six cases occurring in three generations of one family. Brain 1932:55:47.
45. [44] Oliver CP, McQuarrie I, Ziegler M. Hereditary periodic paralysis in family showing varied manifestations. Am J Dis Child 1944;68:308.
46. [45] Myers WA. Familial periodic paralysis is traced in one family for five generations. Penn Med J 1949;52:1060.
47. [46] Helweg-Larson HF, Hauge M, Sagild E. Hereditary transient muscle paralysis in Denmark. Acta Genet (Basel) 1955;5:263-280.
48. [47] Dunkle LM, Diggs CH, Bergman RA, et al. A light and electron microscopic study of a second case of hypokalemic periodic paralysis with hyperthyroidism. Johns Hopkins Med J 1970;126:225-236.
49. [48] Jackman RL, Jones RE. Hyperthyroidism and periodic paralysis. Arch Intern Med 1964;113:657-664.
50. [49] Kelly TM, Fishman LM. Thyrotoxic periodic paralysis in a black male. J Endocrinol Invest 1984;7:517-519.
51. [50] Minns G, Nowlin NS, Day H. Hyperthyroidism and periodic paralysis. Hypokalemia in a black patient. J Kansas Med Soc 1978;79:509-510.
52. [51] Norris FH Jr. Use of acetazolamide in thyrotoxic periodic paralysis (Letter). N Engl J Med 1972;286:893.
53. [52] Satoyoshi E, Murakami K, Kowa H, et al. Periodic paralysis in hyperthyroidism. Neurology 1963;13:746-752.
54. [53] Shulkin D, Olson BR, Levey GS. Case report: thyrotoxic periodic paralysis in a Latin-American taking acetazolamide. Am J Med Sci 1989;297:337-338.
55. [54] Haber RS, Loeb JN. Effect of 3,5,3′-triiodothyronine treatment on potassium efflux from isolated rat diaphragm: role of increased permeability in the thermogenic response. Endocrinology 1982;111:1217-1223.
56. [55] Rubython EJ, Cumberbatch M, Morgan DB. Changes in the number and activity of sodium pumps in erythrocytes from patients with hyperthyroidism. Clin Sci 1983;64:441-447.
57. [56] Kjeldsen K, Norgaard A, Gotzche CO, et al. Effect of thyroid function on number of Na-K pumps in human skeletal muscle. Lancet 1984;2:8-10.
58. [57] Layzer RB. Periodic paralysis and the sodium-potassium pump. Ann Neurol 1982;11:547-552.
59. [58] Sterns RH, Spital A. Disorders of internal potassium balance. Semin Nephrol 1987;7:399-415.
60. [59] Levey GS. Catecholamine-thyroid hormone interactions and the cardiovascular manifestions of hyperthyroidism. Am J Med 1990;88:642-646.
61. [60] Engel AG. Neuromuscular manifestations of Graves' disease. Mayo Clin Proc 1972;47:919-925.
62. [61] Epstein FH, Rosa RM. Adrenergic control of serum potassium. N Engl J Med 1983;309:1450-1451.
63. [62] Yeung RTT, Au KS. Certain biochemical abnormalities in thyrotoxic periodic paralysis. In: Cheah JS, Lim P, Tambyah JA, et al., eds. Proceedings of the Sixth Asia and Oceania Congress of Endocrinology. Singapore: Stamford College Press, 1978;300-307.
64. 2-receptor stimulation by circulating epinephrine. N Engl J Med 1983;309:1414-1419.
65. [64] Engel AG. Electron microscopic observations in primary hypokalemic and thyrotoxic paralysis. Mayo Clin Proc 1966;41:797-808.
66. [65] Bernard JD, Larson MA, Norris FH Jr. Thyrotoxic periodic paralysis in Californians of Mexican and Filipino ancestry. Calif Med 1972;116:70-74.
67. [66] Guthrie GP Jr, Curis JJ, Beilman JM. Hypophosphatemia in thyrotoxic periodic paralysis. Arch Intern Med 1978;138:1284-1285.
68. [67] Au KS, Yeung RTT. Thyrotoxic periodic paralysis. Periodic variation in the muscle calcium pump activity. Arch Neurol 1972;26:543-546.
69. [68] Bergman RA, Afifi AK, Dunkle LM, et al. Muscle pathology in hypokalemic periodic paralysis with hyperthyroidism. I. High resolution light microscopic study of a case. Johns Hopkins Med J 1970;126:88-99.
70. [69] Bergman RA, Afifi AK, Dunkle LM, et al. Muscle pathology in hypokalemic periodic paralysis with hyperthyroidism. II. High resolution light microscopic study of a case. Johns Hopkins Med J 1970;126:100-118.
71. [70] Cheah JS, Tock EPC, Kan SP. The light and electron microscopic changes in the skeletal muscles during paralysis in thyrotoxic periodic paralysis. Am J Med Sci 1975;269:365-374.
72. [71] Takagi A, Schotland DL, DiMauro S, et al. Thyrotoxic periodic paralysis. Function of sarcoplasmic reticulum and muscle glycogen. Neurology 1973;23:1008-1016.
73. [72] Feeley J Potassium shift in thyrotoxic periodic paralysis. Postgrad Med J 1981;57:238-239.
74. [73] Griggs RC, Engel WK, Resnick JS. Acetazolamide treatment of hypokalemic periodic paralysis. Prevention of attacks and improvement of persistent weakness. Ann Intern Med 1970;73:39-48.
75. [74] Resnick JS, Engel WK, Griggs RC, et al. Acetazolamide prophylaxis in hypokalemic periodic paralysis. N Engl J Med 1968;278:582-586.
76. [75] Narins RG, Joens ER, Stom MC, Rudnick MR, Bastl CP. Diagnostic strategies in disorders of fluid, electrolyte and acid-base homeostasis. Am J Med 1982;72:469-520.
77. [76] Oh MS, Taylor EA, Yeo S, et al. Cation transport across lymphocyte plasma membranes in euthyroid and thyrotoxic men with and without hypokalemic periodic paralyses. Clin Sci 1990;78:199-206.